James Sheppard

Oct 31, 2024 | bjgp.org | James Sheppard |Richard McManus

Antihypertensive treatment in older adults Antihypertensive medications are commonly prescribed in primary care1 and are effective at preventing cardiovascular disease in patients of all ages.2 However, treatment is not without harm, with trials showing an increased risk of hypotension, syncope, acute kidney injury, hyperkalaemia, hypokalaemia and hyponatremia with antihypertensive treatment, particularly in older and/ or patients with increasing frailty.3,4 Such patients also have an...

Mar 20, 2024 | columbian.com | James Sheppard

Rents, property taxes, groceries, gasoline, health care, energy and utilities, medical and dental care and so on are all on an inflationary tear. We all are experiencing this. My family is on a fixed income, as many in Ridgefield are. Many families are struggling to just get by, day to day. Many families live in rentals and it’s a near national scandal how much rents have gone up in the last few years.

Jan 11, 2024 | pharmaphorum.com | James Sheppard

The life sciences industry is constantly evolving. With tight budgets, shifting priorities, and the way we work changing for good, life sciences companies need to keep pace with employee and investor demands ‐ or risk being left behind their competitors. As the life sciences sector continues to evolve with the rise in digital health, continuous development of preventative and personalised treatments, and to cope with the challenges of ageing populations, its workspace requirements must evolve too.

Dec 22, 2023 | pharmaceuticalmanufacturer.media | James Sheppard |Jai McIntosh

James Sheppard, Managing Director (UK&I) at Kadans. Since the pandemic, the life sciences industry has experienced highs and lows. From a boom in demand to waning investment, organisations have had to constantly adapt to macro-pressures. With squeezed budgets thanks to the cost-of-living crisis and the way that we all work changing for good, life sciences companies need to rethink their priorities — or risk the future of their organisation.

Aug 21, 2023 | biospace.com | James Sheppard

A key pledge from the new government during the leadership elections in August was to make the UK a ‘Scientific Superpower’, providing opportunity and spreading prosperity in every part of the UK. A great ambition, but in practical terms, what does this mean? The two building blocks of becoming a ‘Scientific Superpower’ are infrastructure and skill set.